brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['hodgkin', 'lymphoma', 'congrat', 'nivo', 's1826']
what an exciting day for adult and peds lymphoma providers &amp; the hodgkin s community! s1826 shows improvement in 1-year pfs of nivo-avd over bv-avd as a collaboration of the peds and adult cooperative groups in the us and canada. congrats dr. herrera and the s1826 team! #asco2023 
Lymphoma doctor, clinical researcher, associate program director; Associate Professor at Wash U in St. Louis. Views and opinions are my own.